Nanoviricides Inc (NNVC) Stock Price, Quote & News

Company Profile

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gumm...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 937 6137

Website: www.nanoviricides.com

Address:

1 Controls Drive, Shelton, United States

Love1010 Jun. 3 at 2:20 PM

$NNVC one again I nailed the bearish move in this stock! This stock is always a pump dump!

0 · Reply

Love1010 Jun. 2 at 1:52 PM

$NNVC look how dumb @STRAYNUT is. He doesn't know the voucher is worthless since this company has no approved drug. I will be you that this stock drifts post June 7.

0 · Reply

STACKD0E Jun. 2 at 4:19 AM

$NNVC $MRK $LAKE $AEMD

0 · Reply

STRAYNUT Jun. 1 at 8:10 PM

$NNVC: You sellers today are going to kick yourselves! Doesn't June 7th mean anything to you? Nano filed an application on April 7th for an RPDD for measles, which must be awarded within 60 days, and will be joined together with the earlier ODD application, which was approved May 4th. The designation comes with a mandated voucher which can be sold, once the measles drug is proven, to a BPh for as much as $180 million. No other $35 million cap company has EVER received such a kicker!!!

0 · Reply

Love1010 Jun. 1 at 7:32 PM

$NNVC don't panic. You knew it had to go back down. No phase II testing, ebola hype, dilution, and high volume shorts are in control!

0 · Reply

ZTRADEZ_LLC May. 29 at 1:46 PM

$NNVC | Loving this chart setup here *Sponsored Communicated Disclaimer https://www.ztradez.net/communicated-disclaimer2 $DELL $ASTS

0 · Reply

crainiac May. 29 at 11:42 AM

$SNGX $NNVC $INO Kenyan court blocks opening of U.S. Ebola quarantine center on air base https://www.cbsnews.com/news/ebola-us-kenya-court-blocks-american-quarantine-center-laikipia-air-base/

0 · Reply

Love1010 May. 28 at 9:33 AM

$NNVC there you go....learn

1 · Reply

Love1010 May. 28 at 9:32 AM

$NNVC time to dump the junk

0 · Reply

Love1010 May. 28 at 9:31 AM

$NNVC mistakes were made

1 · Reply

In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides

May 18, 2026, 11:55 PM EDT - 16 days ago

NanoViricides Announces Closing of ~$2 Million Registered Direct Offering

2026-05-18T12:35:07.000Z - 16 days ago

NanoViricides emphasizes need for Ebolavirus antiviral drug

May 18, 2026, 8:30 AM EDT - 16 days ago

Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides

2026-05-15T15:36:54.000Z - 19 days ago

NanoViricides prices $2M registered direct offering

2026-05-15T13:02:44.000Z - 19 days ago

NanoViricides reports Q1 EPS (9c) vs. (14c) last year

May 15, 2026, 8:35 AM EDT - 19 days ago

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering

May 15, 2026, 8:00 AM EDT - 19 days ago

NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II

2026-05-11T15:05:03.000Z - 23 days ago

NanoViricides says hantavirus incident highlights need for antiviral drugs

May 11, 2026, 8:30 AM EDT - 23 days ago

Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides

May 6, 2026, 3:37 PM EDT - 4 weeks ago

NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference

2026-05-04T13:06:44.000Z - 4 weeks ago

NanoViricides announces NV-387 granted ODD by U.S. FDA OOPD

May 4, 2026, 8:30 AM EDT - 4 weeks ago

NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA

2026-04-28T16:50:20.000Z - 5 weeks ago

NanoViricides measles virus treatment granted FDA orphan status

2026-04-21T12:55:54.000Z - 6 weeks ago

NanoViricides says NV-387 can help control spread of measles

Apr 21, 2026, 8:30 AM EDT - 6 weeks ago

Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides

2026-04-07T14:27:12.000Z - 2 months ago

NanoViricides files application for RPDD for NV-387 with U.S. OPDD

Apr 7, 2026, 8:30 AM EDT - 2 months ago

Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides

2026-04-01T12:48:44.000Z - 2 months ago

NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox

Apr 1, 2026, 8:30 AM EDT - 2 months ago

Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides

2026-03-11T12:46:48.000Z - 3 months ago

NanoViricides completes manufacture of NV-387 oral gummies

Mar 11, 2026, 8:30 AM EDT - 3 months ago

NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete

2026-02-12T13:50:37.000Z - 3 months ago

NanoViricides files application for orphan drug designation for NV-387

Feb 12, 2026, 8:30 AM EST - 3 months ago

MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

2026-02-10T13:41:20.000Z - 4 months ago

NanoViricides files application for orphan drug designation for NV-387

Feb 10, 2026, 8:30 AM EST - 4 months ago

Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

Feb 2, 2026, 8:30 AM EST - 4 months ago

NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres

2026-01-13T14:02:39.000Z - 5 months ago

NanoViricides comments on need for broad-spectrum antivirals

Jan 13, 2026, 8:30 AM EST - 5 months ago

NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2

2025-12-16T12:05:43.000Z - 6 months ago

NanoViricides initiated with a Buy at Alliance Global

2025-12-15T21:30:31.000Z - 6 months ago

NanoViricides files to sell 7.14 shares of common stock for holders

2025-12-01T13:45:20.000Z - 6 months ago

NanoViricides signs Master Services Agreement with Only Orphans Cote

Dec 1, 2025, 8:30 AM EST - 6 months ago

NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles

2025-11-17T13:55:34.000Z - 7 months ago

NanoViricides reports Q3 EPS (10c) vs. (23c) last year

Nov 17, 2025, 8:30 AM EST - 7 months ago

NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position

Nov 14, 2025, 8:30 AM EST - 7 months ago

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

Nov 12, 2025, 5:01 PM EST - 7 months ago

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

2025-11-11T13:45:42.000Z - 7 months ago

NanoViricides prices 3.57M shares at $1.68 in registered direct offering

Nov 11, 2025, 8:30 AM EST - 7 months ago

NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

2025-11-10T14:20:58.000Z - 7 months ago

NanoViricides receives approval to start Phase II trial of NV-387

Nov 10, 2025, 8:30 AM EST - 7 months ago

NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo

Nov 5, 2025, 8:30 AM EST - 7 months ago

NanoViricides Annual Shareholders Meeting to be Held at 10 am on Saturday, November 5th at on Saturday, November 8, 2025, at the Hampton Inn & Suites Stamford, CT

Nov 3, 2025, 8:30 AM EST - 7 months ago

NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd

Oct 29, 2025, 8:45 AM EDT - 7 months ago

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive

Oct 27, 2025, 8:45 AM EDT - 7 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

Oct 22, 2025, 8:45 AM EDT - 8 months ago

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

Oct 20, 2025, 8:45 AM EDT - 8 months ago

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus

Oct 15, 2025, 8:45 AM EDT - 8 months ago

NanoViricides Dual Track Clinical Strategy Explained by a Research Report - Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses

Sep 30, 2025, 8:45 AM EDT - 8 months ago

NanoViricides, Inc. Has Filed its Annual Report

Sep 11, 2025, 8:30 AM EDT - 9 months ago

RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

Sep 9, 2025, 8:30 AM EDT - 9 months ago

NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

Aug 18, 2025, 8:30 AM EDT - 10 months ago

A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials

Jul 30, 2025, 8:30 AM EDT - 11 months ago

Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides

Jul 23, 2025, 8:30 AM EDT - 11 months ago

NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value

Jul 21, 2025, 6:30 AM EDT - 11 months ago

Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides

Jul 16, 2025, 8:30 AM EDT - 11 months ago

WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides

Jun 18, 2025, 6:30 AM EDT - 1 year ago

With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan

Jun 4, 2025, 6:55 AM EDT - 1 year ago

NanoViricides Measles Drug Development Animal Study is Imminent

May 28, 2025, 6:30 AM EDT - 1 year ago

NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025

May 22, 2025, 6:30 AM EDT - 1 year ago

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan

May 14, 2025, 6:30 AM EDT - 1 year ago

Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution

May 5, 2025, 6:30 AM EDT - 1 year ago

NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC

Apr 29, 2025, 6:30 AM EDT - 1 year ago

Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It

Apr 14, 2025, 6:30 AM EDT - 1 year ago

Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak

Mar 11, 2025, 6:30 AM EDT - 1 year ago

NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

Mar 4, 2025, 6:30 AM EST - 1 year ago

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

Feb 19, 2025, 6:30 AM EST - 1 year ago

NanoViricides, Inc. Has Filed its Quarterly Report

Feb 11, 2025, 6:30 AM EST - 1 year ago

NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

Jan 29, 2025, 6:30 AM EST - 1 year ago

NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

Love1010 Jun. 3 at 2:20 PM

$NNVC one again I nailed the bearish move in this stock! This stock is always a pump dump!

0 · Reply

Love1010 Jun. 2 at 1:52 PM

$NNVC look how dumb @STRAYNUT is. He doesn't know the voucher is worthless since this company has no approved drug. I will be you that this stock drifts post June 7.

0 · Reply

STACKD0E Jun. 2 at 4:19 AM

$NNVC $MRK $LAKE $AEMD

0 · Reply

STRAYNUT Jun. 1 at 8:10 PM

0 · Reply

Love1010 Jun. 1 at 7:32 PM

$NNVC don't panic. You knew it had to go back down. No phase II testing, ebola hype, dilution, and high volume shorts are in control!

0 · Reply

ZTRADEZ_LLC May. 29 at 1:46 PM

$NNVC | Loving this chart setup here *Sponsored Communicated Disclaimer https://www.ztradez.net/communicated-disclaimer2 $DELL $ASTS

0 · Reply

crainiac May. 29 at 11:42 AM

$SNGX $NNVC $INO Kenyan court blocks opening of U.S. Ebola quarantine center on air base https://www.cbsnews.com/news/ebola-us-kenya-court-blocks-american-quarantine-center-laikipia-air-base/

0 · Reply

Love1010 May. 28 at 9:33 AM

$NNVC there you go....learn

1 · Reply

Love1010 May. 28 at 9:32 AM

$NNVC time to dump the junk

0 · Reply

Love1010 May. 28 at 9:31 AM

$NNVC mistakes were made

1 · Reply

Arthur86 May. 28 at 7:54 AM

$KULR Biggest potential for a jump today IMO $BBAI $LCID $NNVC $SMCI

0 · Reply

DavidScott May. 28 at 3:45 AM

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $NNVC $KULR $BBAI $LCID $SMCI

1 · Reply

STRAYNUT May. 28 at 1:27 AM

$NNVC Remember June 7th, 2026!!! That is the date by which Nano will be granted for Measles the designation "Rare Pediatric Disease Drug (RPDD), which MANDATES that a voucher is attached, which when the drug is proven to work***, the voucher can be sold to a Big Pharma for as much as $180 MILLION! *** NV-387 is the ONLY drug candidate known to Dr. Diwan that has "demonstrated strong in vivo activity against lethal infection with the Measles virus in a humanized animal model study".

0 · Reply

STRAYNUT May. 28 at 1:13 AM

$NNVC Short Interest (05/15/26) Shares Sold Short 702,023 Change from Last -1.63% Percent of Float 3.34% https://www.wsj.com/market-data/quotes/NNVC

0 · Reply

Stock_Catcher May. 28 at 1:06 AM

Treasure Thursday Watchlist Ebola Theme $CODX $SNGX $TRAW $AEMD $NNVC

0 · Reply

roguebard1 May. 27 at 7:56 PM

$NNVC In!

0 · Reply

DavidScott May. 27 at 7:50 PM

$ASTC $NNVC $KULR $BBAI $LCID = Let's goooo! It was a great session with some awesome movers. The bulls were strong this round! These were our main plays, and we are expecting even more action on these names again going into Thursday. If you need any guidance or a mentor, then feel free to join us anytime! ✅🙌 I'll see you all back here later this evening! Have a great rest of the day everybody 🎉

0 · Reply